Elevated High-Sensitivity Troponin I in the Stabilized Phase after na Acute Coronary Syndrome Predicts All-Cause and Cardiovascular Mortality in a Highly Admixed Population: A 7-Year Cohort
Authors:
- Leandro Teixeira de CastroLCLeandro Teixeira de Castro
- Itamar de Souza SantosISItamar de Souza Santos
- Alessandra C. GoulartAGAlessandra C. Goulart
- Alexandre da Costa PereiraAPAlexandre da Costa Pereira
- Henrique Lane StaniakHSHenrique Lane Staniak
- Marcio Sommer BittencourtMBMarcio Sommer Bittencourt
- Paulo Andrade LotufoPLPaulo Andrade Lotufo
- Isabela Martins BensenorIBIsabela Martins Bensenor
Open Access
- 1 January 2018
- journal article
- research article
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
- Vol. 112 (3) , 230-237
Abstract
High-sensitivity cardiac troponin I (hs-cTnI) has played an important role in the risk stratification of patients during the in-hospital phase of acute coronary syndrome (ACS), but few studies have determined its role as a long-term prognostic marker in the outpatient setting. To investigate the association between levels of hs-cTnI measured in the subacute phase after an ACS event and long-term prognosis in a highly admixed population. We measured levels of hs-cTnI in 525 patients 25 to 90 days after admission for an ACS event; these patients were then divided into tertiles according to hs-cTnI levels and followed for up to 7 years. We compared all-cause and cardiovascular mortality using Cox proportional hazards models and adopting a significance level of 5%. After a median follow-up of 51 months, patients in the highest tertile had a greater hazard ratio (HR) for all-cause mortality after adjustment for age, sex, known cardiovascular risk factors, medication use, and demographic factors (HR: 3.84, 95% CI: 1.92-8.12). These findings persisted after further adjustment for estimated glomerular filtration rate < 60 ml/min/1.73 m2 and left ventricular ejection fraction < 0.40 (HR: 6.53, 95% CI: 2.12-20.14). Cardiovascular mortality was significantly higher in the highest tertile after adjustment for age and sex (HR: 5.65, 95% CI: 1.94-16.47) and both in the first (HR: 4.90, 95% CI: 1.35-17.82) and second models of multivariate adjustment (HR: 5.89, 95% CI: 1.08-32.27). Elevated hs-cTnI levels measured in the stabilized phase after an ACS event are independent predictors of all-cause and cardiovascular mortality in a highly admixed population.Keywords
This publication has 33 references indexed in Scilit:
- The prognostic value of high sensitivity troponin T 7 weeks after an acute coronary syndromeHeart, 2012
- Prognostic Usefulness of Circulating High-Sensitivity Troponin T in Aortic Stenosis and Relation to Echocardiographic Indexes of Cardiac Function and AnatomyThe American Journal of Cardiology, 2011
- Pathobiology of Troponin ElevationsJACC, 2011
- Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponinAmerican Heart Journal, 2011
- Trends in Incidence, Severity, and Outcome of Hospitalized Myocardial InfarctionCirculation, 2010
- A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2009
- The expanded Global Registry of Acute Coronary Events: Baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromesAmerican Heart Journal, 2009
- Persistent Cardiac Troponin I Elevation in Stabilized Patients After an Episode of Acute Coronary Syndrome Predicts Long-Term MortalityCirculation, 2007
- Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart FailureCirculation, 2007
- Apoptosis in the Failing Human HeartNew England Journal of Medicine, 1997